Delivery Order SPE2DB20D3101-SPE2DB22FQVL5
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.27 Delivery Order is for the supply of Rizatriptan 10 mg Orally Disintegrating Tablets (ODTs), a medication used to treat migraine headaches. The contract has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,896.14 firm fixed-price delivery order is for the supply of 4560678275 units of Rizatriptan 10 mg tablets, an acute migraine medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, which runs through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Rizatriptan 10 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $1,004.38 and is a firm fixed-price, indefinite delivery vehicle with a completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,618.81 Firm Fixed Price delivery order is for the supply of Rizatriptan 10 mg orally disintegrating tablets, a medication used to treat migraines. The contract does not have a set-aside designation, indicating open competition. It is associated with Amerisourcebergen's larger Indefinite...
- This federal contract award, valued at $1,826.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,554,932,696 units of Rizatriptan 5 mg Orally Disintegrating Tablets (ODT), a medication used to treat migraine headaches. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award, valued at $15,260.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of rizatriptan 10 mg ODT UD 18s, a prescription migraine medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $2,320.18 contract is for the delivery of 4,563,966,595 units of rizatriptan 10 mg orally disintegrating tablets, a migraine medication, to support military treatment programs and facilities. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,322.72 firm fixed-price contract is for the supply of Rizatriptan 10 mg Orally Disintegrating Tablets, a medication used to treat migraine headaches. The contract has an ultimate completion date of May 10, 2023. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,167.20 Firm Fixed Price delivery order is for the supply of Rizatriptan 5 mg tablets, a medication commonly used to treat migraines. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,867.38 firm fixed-price delivery order covers the supply of 4,563,750,623 units of Rizatriptan 10 mg tablets for an ultimate completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQVL5Delivery Order
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $2,023.32. The contract is for the delivery of 4,558,533,470 units of Rizatriptan 10 mg Tablet, a prescription medication used to treat migraine headaches. The contract has a period of performance through September 21, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which supports the procurement of essential medical products for federal healthcare programs, particularly the military and veterans' healthcare systems. The DLA Troop Support Medical IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical and medical supplies to the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/20/22 |